AstraZeneca PLC
NASDAQ:AZN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AstraZeneca PLC
NASDAQ:AZN
|
UK |
|
L
|
Lam Soon Thailand PCL
SET:LST
|
TH |
|
S
|
Sanlam Ltd
JSE:SLM
|
ZA |
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
Nandan Denim Ltd
NSE:NDL
|
IN |
|
Tesoro Resources Ltd
ASX:TSO
|
AU |
|
ABG Sundal Collier Holding ASA
OSE:ABG
|
NO |
|
Saga Pure ASA
OSE:SAGA
|
NO |
|
Lisata Therapeutics Inc
NASDAQ:LSTA
|
US |
|
Pritish Nandy Communications Ltd
NSE:PNC
|
IN |
|
eFFECTOR Therapeutics Inc
OTC:EFTR
|
US |
|
K
|
Kfin Technologies Ltd
NSE:KFINTECH
|
IN |
|
M
|
Monnari Trade SA
WSE:MON
|
PL |
|
Tan Chong International Ltd
HKEX:693
|
HK |
|
W
|
Wellchange Holdings Co Ltd
NASDAQ:WCT
|
HK |
|
Moelis & Co
NYSE:MC
|
US |
|
Batulicin Nusantara Maritim Tbk PT
IDX:BESS
|
ID |
|
M
|
MicroAlgo Inc
NASDAQ:MLGO
|
US |
|
LPP SA
WSE:LPP
|
PL |
|
H
|
Hokushin Co Ltd
TSE:7897
|
JP |
|
Azure Minerals Ltd
ASX:AZS
|
AU |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
K
|
Komplett Bank ASA
OSE:KOMP
|
NO |
|
S
|
Stadio Holdings Ltd
JSE:SDO
|
ZA |
Wall Street
Price Targets
AZN Price Targets Summary
AstraZeneca PLC
According to Wall Street analysts, the average 1-year price target for
AZN
is 208.02 USD
with a low forecast of 89.2 USD and a high forecast of 287.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AZN's stock price target?
Price Target
208.02
USD
According to Wall Street analysts, the average 1-year price target for
AZN
is 208.02 USD
with a low forecast of 89.2 USD and a high forecast of 287.5 USD.
What is AstraZeneca PLC's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
AstraZeneca PLC's revenue is
4%.
The projected
CAGR
for the next 3 years is
7%.
What is AstraZeneca PLC's Operating Income forecast?
Projected CAGR
21%
For the last 14 years the
compound annual growth rate for
AstraZeneca PLC's operating income is
2%.
The projected
CAGR
for the next 3 years is
21%.
What is AstraZeneca PLC's Net Income forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
AstraZeneca PLC's net income is
0%.
The projected
CAGR
for the next 3 years is
26%.
